Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer

European Journal of Surgical Oncology

Volumn 35, Issue 6, 2009, Pages 588-592

  Muratore, A ^a   Zimmitti, G ^a   Lo Tesoriere, R ^a   Mellano, A ^a   Massucco, P ^a   Capussotti, L ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Gastric cancer; Lymph nodes; Radiotherapy; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; DATA BASE; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; RETROSPECTIVE STUDY; STOMACH CARCINOMA;

ADENOCARCINOMA; DATABASES AS TOPIC; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 67349163639     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.12.012     Document Type: Article

References (23)

1. Inghelman R., Grande E., Francisi S., et al. Tumori 93 4 (2007) 367-373
2. Brennan F.M. Current status for gastric cancer: a review. Gastric Cancer 8 (2005) 64-70 DOI: 10.1007/S10120-005-0319-6
3. Sano T. Tailoring treatments for curable gastric cancer. Br J Surg 94 (2007) 263-264 DOI: 10.1002/BJS.5785
4. Sasako M., McCulloch P., Kinoshita T., and Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82 (1995) 346-351
5. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 7 4 (2006) 309-315
6. Hartgrink H.H., van de Velde C.J.H., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. JCO 22 11 (2004) 1-9 DOI 10.1200/JCO.2004.08.026
7. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79 (1999) 1522-1530
8. Otsuji E., Kuriu Y., Ichkawa D., et al. Time to death and pattern of recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg 28 (2004) 866-869
9. Yoo C.H., Noh S.H., Shin D.W., Choi S.H., and Min J.S. Recurrence following curative resection for gastric carcinoma. Br J Surg 87 (2000) 236-242
10. MacDonald J.S., Smalley S., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
11. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
12. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. JCO 22 14 (2004) 1-7 DOI: 10.1200/JCO.2004.10.184
13. Kunisaki C., Akiyama H., Nomura M., et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol 13 5 (2007) 659-667 DOI: 10.1245/ASO.2006.07.015
14. Bonekamp J.J., Hermans J., and Sasako M. Van de Velde CJH for the Dutch Gastric cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
15. Otsuji E., Yamaguchi T., Sawai K., Okamoto K., and Takahashi T. End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma. Br J Cancer 75 8 (1997) 1219-1223
16. Degiuli M., Sasako M., Ponti A., and Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90 9 (2004) 1727-1732
17. Biffi R., Chiappa A., Luca F., et al. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 93 (2006) 394-400
18. Kodera Y., Schwarz R.E., and Nakao A. Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials?. J Am Coll Surg 195 6 (2002) 855-864 DOI: 10.1016/S1072-7515(02)01496-5
19. Rogginn K.K., and Posner M.C. D3 or not D3 that is not the question. Lancet Oncol 7 (2006) 309-315
20. Karpeh M., Leon L., Klimstra D., and Brennan M.F. Lymph node staging in gastric cancer: is location more important than number?. Ann Surg 232 (2000) 362-371
21. Landry J., Tepper J.E., Wood W.C., Moulton E.O., Koerner F., and Sullinger J. patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 19 (1990) 1357-1362
22. Coburn N.G., Guller U., Baxter N.N., et al. Adjuvant therapy for resected gastric cancer - rapid, yet incomplete adoption following results of intergroup 0116 trial. Int J Radiat Oncol Biol Phys 70 4 (2008) 1073-1080 DOI:10.1016/j.ijrobp.2007.07.2378
23. Lim D.H., Kang M.K., Kim Y.I., et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer 91 (2004) 11-17